It is generally believed that ANGPT2, as an antagonist of ANGPT1, competitively binds to its specific tyrosine kinase receptors-2 (Tie-2) receptors and blocks the vascular-stabilizing effect of Ang-1, leading to sustained neovascularization in tumor tissues [40]. The gene discussed is ANGPT2; the disease is neoplasm.